COVID-19 starkly exposed shortcomings in the global system for funding research into infectious diseases and ensuring equity of access to vaccines and therapies, according to Wolfgang Philipp, acting director of the Health Emergency Preparedness and Response Authority, the new EU agency set up in the wake of the pandemic.